Establishment of metabolism and transport pathways in the rodent and human fetal liver

International Journal of Molecular Sciences

Volumn 14, Issue 12, 2013, Pages 23801-23827

  Moscovitz, Jamie E ^a   Aleksunes, Lauren M ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Abc; Fetal; Metabolism; Ontogeny; Phase I; Phase II; Prenatal; Regulation; Slc; Transport

Indexed keywords

ACYLTRANSFERASE; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; CARBOXYLESTERASE; CYTOCHROME P450; DIMETHYLANILINE MONOOXYGENASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; MESSENGER RNA; SULFOTRANSFERASE; CARRIER PROTEIN; TRANSFERASE;

BILIARY EXCRETION; BIOTRANSFORMATION; DRUG EXCRETION; DRUG TRANSPORT; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; LIVER DEVELOPMENT; LIVER FUNCTION; NONHUMAN; ONTOGENY; PHASE 1 METABOLISM; PHASE 2 METABOLISM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; REVIEW; RNA SEQUENCE; TRANSPORT KINETICS; ANIMAL; ENZYMOLOGY; FETUS DEVELOPMENT; GROWTH, DEVELOPMENT AND AGING; LIVER; METABOLISM;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; FETAL DEVELOPMENT; HUMANS; LIVER; MEMBRANE TRANSPORT PROTEINS; TRANSFERASES;

EID: 84889815284     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141223801     Document Type: Review

References (101)

1. Fouts, J.R.; Adamson, R.H. Drug metabolism in the newborn rabbit. Science 1959, 129, 897-898.
2. Alnouti, Y.; Klaassen, C.D. Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. Toxicol. Sci. 2008, 101, 51-64.
3. Peng, L.; Cui, J.Y.; Yoo, B.; Gunewardena, S.S.; Lu, H.; Klaassen, C.D.; Zhong, X.B. RNA-sequencing quantification of hepatic ontogeny of phase-I enzymes in mice. Drug Metab. Dispos. 2013, 41, 2175-86.
4. Cherrington, N.J.; Cao, Y.; Cherrington, J.W.; Rose, R.L.; Hodgson, E. Physiological factors affecting protein expression of flavin-containing monooxygenases 1, 3 and 5. Xenobiotica 1998, 28, 673-682.
5. Dolphin, C.T.; Cullingford, T.E.; Shephard, E.A.; Smith, R.L.; Phillips, I.R. Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavin-containing monooxygenase family of man, FMO1, FMO3 and FM04. Eur. J. Biochem. 1996, 235, 683-689.
6. Yeung, C.K.; Lang, D.H.; Thummel, K.E.; Rettie, A.E. Immunoquantitation of FMO1 in human liver, kidney, and intestine. Drug Metab. Dispos. 2000, 28, 1107-1111.
7. De Zwart, L.; Scholten, M.; Monbaliu, J.G.; Annaert, P.P.; van Houdt, J.M.; van den Wyngaert, I.; de Schaepdrijver, L.M.; Bailey, G.P.; Coogan, T.P.; Coussement, W.C.; et al. The ontogeny of drug metabolizing enzymes and transporters in the rat. Reprod. Toxicol. 2008, 26, 220-230.
8. Yang, D.; Pearce, R.E.; Wang, X.; Gaedigk, R.; Wan, Y.J.; Yan, B. Human carboxylesterases HCE1 and HCE2: Ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin. Biochem. Pharmacol. 2009, 77, 238-247.
9. Choudhary, D.; Jansson, I.; Schenkman, J.B.; Sarfarazi, M.; Stoilov, I. Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch. Biochem. Biophys. 2003, 414, 91-100.
10. Nelson, D.R.; Zeldin, D.C.; Hoffman, S.M.; Maltais, L.J.; Wain, H.M.; Nebert, D.W. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 2004, 14, 1-18.
11. Hart, S.N.; Cui, Y.; Klaassen, C.D.; Zhong, X.B. Three patterns of cytochrome P450 gene expression during liver maturation in mice. Drug Metab. Dispos. 2009, 37, 116-121.
12. Sonnier, M.; Cresteil, T. Delayed ontogenesis of CYP1A2 in the human liver. Eur. J. Biochem. 1998, 251, 893-898.
13. Choudhary, D.; Jansson, I.; Stoilov, I.; Sarfarazi, M.; Schenkman, J.B. Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch. Biochem. Biophys. 2005, 436, 50-61.
14. Peng, L.; Yoo, B.; Gunewardena, S.S.; Lu, H.; Klaassen, C.D.; Zhong, X.B. RNA sequencing reveals dynamic changes of mRNA abundance of cytochromes P450 and their alternative transcripts during mouse liver development. Drug Metab. Dispos. 2012, 40, 1198-1209.
15. Lee, J.S.; Ward, W.O.; Knapp, G.; Ren, H.; Vallanat, B.; Abbott, B.; Ho, K.; Karp, S.J.; Corton, J.C. Transcriptional ontogeny of the developing liver. BMC Genomics 2012, 13, 33.
16. Omiecinski, C.J.; Hassett, C.; Costa, P. Developmental expression and in situ localization of the phenobarbital-inducible rat hepatic mRNAs for cytochromes CYP2B1, CYP2B2, CYP2C6, and CYP3A1. Mol. Pharmacol. 1990, 38, 462-470.
17. Borlakoglu, J.T.; Scott, A.; Henderson, C.J.; Wolf, C.R. Expression of P450 isoenzymes during rat liver organogenesis. Int J. Biochem. 1993, 25, 1659-1668.
18. Koukouritaki, S.B.; Manro, J.R.; Marsh, S.A.; Stevens, J.C.; Rettie, A.E.; McCarver, D.G.; Hines, R.N. Developmental expression of human hepatic CYP2C9 and CYP2C19. J. Pharmacol. Exp. Ther. 2004, 308, 965-974.
19. De Wildt, S.N.; Kearns, G.L.; Leeder, J.S.; van den Anker, J.N. Cytochrome P450 3A: Ontogeny and drug disposition. Clin. Pharmacokinet 1999, 37, 485-505.
20. Lacroix, D.; Sonnier, M.; Moncion, A.; Cheron, G.; Cresteil, T. Expression of CYP3A in the human liver-Evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur. J. Biochem. 1997, 247, 625-634.
21. Stevens, J.C.; Hines, R.N.; Gu, C.; Koukouritaki, S.B.; Manro, J.R.; Tandler, P.J.; Zaya, M.J. Developmental expression of the major human hepatic CYP3A enzymes. J. Pharmacol. Exp. Ther. 2003, 307, 573-582.
22. Cui, J.Y.; Aleksunes, L.M.; Tanaka, Y.; Fu, Z.D.; Guo, Y.; Guo, G.L.; Lu, H.; Zhong, X.B.; Klaassen, C.D. Bile acids via FXR initiate the expression of major transporters involved in the enterohepatic circulation of bile acids in newborn mice. Am. J. Physiol. Gastrointest Liver Physiol. 2012, 302, G979-996.
23. Cuesta de Juan, S.; Monte, M.J.; Macias, R.I.; Wauthier, V.; Calderon, P.B.; Marin, J.J. Ontogenic development-associated changes in the expression of genes involved in rat bile acid homeostasis. J. Lipid Res. 2007, 48, 1362-1370.
24. Li, X.Y.; Zhang, C.; Wang, H.; Ji, Y.L.; Wang, S.F.; Zhao, L.; Chen, X.; Xu, D.X. Tumor necrosis factor alpha partially contributes to lipopolysaccharide-induced downregulation of CYP3A in fetal liver: Its repression by a low dose LPS pretreatment. Toxicol. Lett. 2008, 179, 71-77.
25. Blanco, J.; Mulero, M.; Domingo, J.L.; Sanchez, D.J. Gestational exposure to BDE-99 produces toxicity through upregulation of CYP isoforms and ROS production in the fetal rat liver. Toxicol. Sci. 2012, 127, 296-302.
26. Cresteil, T.; Beaune, P.; Kremers, P.; Celier, C.; Guengerich, F.P.; Leroux, J.P. Immunoquantification of epoxide hydrolase and cytochrome P-450 isozymes in fetal and adult human liver microsomes. Eur. J. Biochem. 1985, 151, 345-350.
27. Shimada, T.; Yamazaki, H.; Mimura, M.; Wakamiya, N.; Ueng, Y.F.; Guengerich, F.P.; Inui, Y. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab. Dispos. 1996, 24, 515-522.
28. Treluyer, J.M.; Cheron, G.; Sonnier, M.; Cresteil, T. Cytochrome P-450 expression in sudden infant death syndrome. Biochem. Pharmacol. 1996, 52, 497-504.
29. Hines, R.N. Ontogeny of human hepatic cytochromes P450. J. Biochem. Mol. Toxicol. 2007, 21, 169-175.
30. Johnsrud, E.K.; Koukouritaki, S.B.; Divakaran, K.; Brunengraber, L.L.; Hines, R.N.; McCarver, D.G. Human hepatic CYP2E1 expression during development. J. Pharmacol. Exp. Ther. 2003, 307, 402-407.
31. Treluyer, J.M.; Jacqz-Aigrain, E.; Alvarez, F.; Cresteil, T. Expression of CYP2D6 in developing human liver. Eur. J. Biochem. 1991, 202, 583-588.
32. Cui, J.Y.; Renaud, H.J.; Klaassen, C.D. Ontogeny of novel cytochrome P450 gene isoforms during postnatal liver maturation in mice. Drug Metab. Dispos. 2012, 40, 1226-1237.
33. Li, Y.; Cui, Y.; Hart, S.N.; Klaassen, C.D.; Zhong, X.B. Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation. Mol. Pharmacol. 2009, 75, 1171-1179.
34. Atterberry, T.T.; Burnett, W.T.; Chambers, J.E. Age-related differences in parathion and chlorpyrifos toxicity in male rats: Target and nontarget esterase sensitivity and cytochrome P450-mediated metabolism. Toxicol. Appl. Pharmacol. 1997, 147, 411-418.
35. Timchalk, C.; Poet, T.S.; Kousba, A.A. Age-dependent pharmacokinetic and pharmacodynamic response in preweanling rats following oral exposure to the organophosphorus insecticide chlorpyrifos. Toxicology 2006, 220, 13-25.
36. Xiao, D.; Chen, Y.T.; Yang, D.; Yan, B. Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation. Biochem. Pharmacol. 2012, 84, 232-239.
37. Zhu, H.J.; Appel, D.I.; Jiang, Y.; Markowitz, J.S. Age-and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver. Drug Metab. Dispos. 2009, 37, 1819-1825.
38. Nahar, M.S.; Kim, J.H.; Sartor M.A.; Dolinoy, D.C. Bisphenol A-associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver. Environ. Mol. Mutagen. 2013, in press.
39. Stoilov, I.; Akarsu, A.N.; Sarfarazi, M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum. Mol. Genet. 1997, 6, 641-647.
40. Balasubramaniyan, N.; Shahid, M.; Suchy, F.J.; Ananthanarayanan, M. Multiple mechanisms of ontogenic regulation of nuclear receptors during rat liver development. Am. J. Physiol. Gastrointest Liver Physiol. 2005, 288, G251-G260.
41. Kamiya, A.; Inoue, Y.; Gonzalez, F.J. Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. Hepatology 2003, 37, 1375-1384.
42. Klaassen, C.D.; Lu, H.; Cui, J.Y. Epigenetic regulation of drug processing genes. Toxicol. Mech. Methods 2011, 21, 312-324.
43. Jin, B.; Park, D.W.; Nam, K.W.; Oh, G.T.; Lee, Y.S.; Ryu, D.Y. CpG methylation of the mouse CYP1A2 promoter. Toxicol. Lett. 2004, 152, 11-18.
44. Lu, H.; Gunewardena, S.; Cui, J.Y.; Yoo, B.; Zhong, X.B.; Klaassen, C.D. RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice. Drug Metab. Dispos. 2013, 41, 844-857.
45. Alnouti, Y.; Klaassen, C.D. Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol. Sci. 2006, 93, 242-255.
46. Richard, K.; Hume, R.; Kaptein, E.; Stanley, E.L.; Visser, T.J.; Coughtrie, M.W. Sulfation of thyroid hormone and dopamine during human development: Ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J. Clin. Endocrinol. Metab. 2001, 86, 2734-2742.
47. Stanley, E.L.; Hume, R.; Coughtrie, M.W. Expression profiling of human fetal cytosolic sulfotransferases involved in steroid and thyroid hormone metabolism and in detoxification. Mol. Cell. Endocrinol. 2005, 240, 32-42.
48. Duanmu, Z.; Weckle, A.; Koukouritaki, S.B.; Hines, R.N.; Falany, J.L.; Falany, C.N.; Kocarek, T.A.; Runge-Morris, M. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre-and postnatal human liver. J. Pharmacol. Exp. Ther. 2006, 316, 1310-1317.
49. Cappiello, M.; Giuliani, L.; Rane, A.; Pacifici, G.M. Dopamine sulphotransferase is better developed than P-nitrophenol sulphotransferase in the human fetus. Dev. Pharmacol. Ther. 1991, 16, 83-88.
50. Pacifici, G.M.; Kubrich, M.; Giuliani, L.; de Vries, M.; Rane, A. Sulphation and glucuronidation of ritodrine in human foetal and adult tissues. Eur. J. Clin. Pharmacol. 1993, 44, 259-264.
51. Miki, Y.; Nakata, T.; Suzuki, T.; Darnel, A.D.; Moriya, T.; Kaneko, C.; Hidaka, K.; Shiotsu, Y.; Kusaka, H.; Sasano, H. Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues. J. Clin. Endocrinol. Metab. 2002, 87, 5760-5768.
52. Parker, C.R., Jr.; Falany, C.N.; Stockard, C.R.; Stankovic, A.K.; Grizzle, W.E. Immunohistochemical localization of dehydroepiandrosterone sulfotransferase in human fetal tissues. J. Clin. Endocrinol. Metab. 1994, 78, 234-236.
53. Barker, E.V.; Hume, R.; Hallas, A.; Coughtrie, W.H. Dehydroepiandrosterone sulfotransferase in the developing human fetus: Quantitative biochemical and immunological characterization of the hepatic, renal, and adrenal enzymes. Endocrinology 1994, 134, 982-989.
54. Cui, J.Y.; Choudhuri, S.; Knight, T.R.; Klaassen, C.D. Genetic and epigenetic regulation and expression signatures of glutathione S-transferases in developing mouse liver. Toxicol. Sci. 2010, 116, 32-43.
55. Tee, L.B.; Gilmore, K.S.; Meyer, D.J.; Ketterer, B.; Vandenberghe, Y.; Yeoh, G.C. Expression of glutathione S-transferase during rat liver development. Biochem. J. 1992, 282, 209-218.
56. Raijmakers, M.T.; Steegers, E.A.; Peters, W.H. Glutathione S-transferases and thiol concentrations in embryonic and early fetal tissues. Hum. Reprod. 2001, 16, 2445-2450.
57. Strange, R.C.; Davis, B.A.; Faulder, C.G.; Cotton, W.; Bain, A.D.; Hopkinson, D.A.; Hume, R. The human glutathione S-transferases: Developmental aspects of the GST1, GST2, and GST3 loci. Biochem Genet. 1985, 23, 1011-1028.
58. Kishi, M.; Emi, Y.; Sakaguchi, M.; Ikushiro, S.; Iyanagi, T. Ontogenic isoform switching of UDP-glucuronosyltransferase family 1 in rat liver. Biochem. Biophys. Res. Commun. 2008, 377, 815-819.
59. Burchell, B.; Coughtrie, M.; Jackson, M.; Harding, D.; Fournel-Gigleux, S.; Leakey, J.; Hume, R. Development of human liver UDP-glucuronosyltransferases. Dev. Pharmacol. Ther. 1989, 13, 70-77.
60. Rollins, D.E.; von Bahr, C.; Glaumann, H.; Moldeus, P.; Rane, A. Acetaminophen: Potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells. Science 1979, 205, 1414-1416.
61. Ekstrom, L.; Johansson, M.; Rane, A. Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus. Drug Metab. Dispos. 2013, 41, 291-295.
62. Pacifici, G.M.; Sawe, J.; Kager, L.; Rane, A. Morphine glucuronidation in human fetal and adult liver. Eur. J. Clin. Pharmacol. 1982, 22, 553-558.
63. Leakey, J.E.; Hume, R.; Burchell, B. Development of multiple activities of UDP-glucuronyltransferase in human liver. Biochem. J. 1987, 243, 859-861.
64. McQueen, C.A.; Mitchell, M.K.; Dang, L.N.; Chau, B.; Tjalkens, R.B.; Philbert, M.A. Prenatal expression of N-acetyltransferases in C57Bl/6 mice. Chem. Biol. Interact. 2003, 145, 77-87.
65. Pacifici, G.M.; Bencini, C.; Rane, A. Acetyltransferase in humans: Development and tissue distribution. Pharmacology 1986, 32, 283-291.
66. Coughtrie, M.W. Sulfation through the looking glass-Recent advances in sulfotransferase research for the curious. Pharmacogenomics J. 2002, 2, 297-308.
67. Her, C.; Kaur, G.P.; Athwal, R.S.; Weinshilboum, R.M. Human sulfotransferase SULT1C1: cDNA cloning, tissue-specific expression, and chromosomal localization. Genomics 1997, 41, 467-470.
68. Hobkirk, R. Steroid sulfotransferases and steroid sulfate sulfatases: Characteristics and biological roles. Can. J. Biochem Cell. Biol. 1985, 63, 1127-1144.
69. Knight, T.R.; Choudhuri, S.; Klaassen, C.D. Constitutive mRNA expression of various glutathione S-transferase isoforms in different tissues of mice. Toxicol. Sci. 2007, 100, 513-524.
70. Thomson, R.E.; Bigley, A.L.; Foster, J.R.; Jowsey, I.R.; Elcombe, C.R.; Orton, T.C.; Hayes, J.D. Tissue-specific expression and subcellular distribution of murine glutathione S-transferase class kappa. J. Histochem. Cytochem. 2004, 52, 653-662.
71. Li, W.; Gu, Y.; James, M.O.; Hines, R.N.; Simpson, P.; Langaee, T.; Stacpoole, P.W. Prenatal and postnatal expression of glutathione transferase zeta 1 in human liver and the roles of haplotype and subject age in determining activity with dichloroacetate. Drug Metab. Dispos. 2012, 40, 232-239.
72. Evans, W.E.; Relling, M.V. Pharmacogenomics: Translating functional genomics into rational therapeutics. Science 1999, 286, 487-491.
73. Mitchell, M.K.; Futscher, B.W.; McQueen, C.A. Developmental expression of N-acetyltransferases in C57BI/6 mice. Drug Metab. Dispos. 1999, 27, 261-264.
74. Araki, Y.; Sakakibara, Y.; Boggaram, V.; Katafuchi, J.; Suiko, M.; Nakajima, H.; Liu, M.C. Tissue-specific and developmental stage-dependent expression of a novel rat Dopa/tyrosine sulfotransferase. Int. J. Biochem. Cell. Biol. 1997, 29, 801-806.
75. Liu, L.; Klaassen, C.D. Ontogeny and hormonal basis of female-dominant rat hepatic sulfotransferases. J. Pharmacol. Exp. Ther. 1996, 279, 386-391.
76. Liu, L.; Klaassen, C.D. Ontogeny and hormonal basis of male-dominant rat hepatic sulfotransferases. Mol. Pharmacol. 1996, 50, 565-572.
77. Sonoda, J.; Xie, W.; Rosenfeld, J.M.; Barwick, J.L.; Guzelian, P.S.; Evans, R.M. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (Pxr). Proc. Natl. Acad. Sci. USA 2002, 99, 13801-13806.
78. Fang, H.L.; Strom, S.C.; Cai, H.; Falany, C.N.; Kocarek, T.A.; Runge-Morris, M. Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor. Mol. Pharmacol. 2005, 67, 1257-1267.
79. Hempel, N.; Wang, H.; LeCluyse, E.L.; McManus, M.E.; Negishi, M. The human sulfotransferase SULT1A1 gene is regulated in a synergistic manner by Sp1 and GA binding protein. Mol. Pharmacol. 2004, 66, 1690-1701.
80. Cui, J.Y.; Gunewardena, S.S.; Yoo, B.; Liu, J.; Renaud, H.J.; Lu, H.; Zhong, X.B.; Klaassen, C.D. RNA-Seq reveals different mRNA abundance of transporters and their alternative transcript isoforms during liver development. Toxicol. Sci. 2012, 127, 592-608.
81. Gao, B.; St Pierre, M.V.; Stieger, B.; Meier, P.J. Differential expression of bile salt and organic anion transporters in developing rat liver. J. Hepatol. 2004, 41, 201-208.
82. Chen, H.L.; Liu, Y.J.; Feng, C.H.; Wu, C.Y.; Shyu, M.K.; Yuan, R.H.; Chang, M.H. Developmental expression of canalicular transporter genes in human liver. J. Hepatol. 2005, 43, 472-477.
83. Sharma, S.; Ellis, E.C.; Gramignoli, R.; Dorko, K.; Tahan, V.; Hansel, M.; Mattison, D.R.; Caritis, S.N.; Hines, R.N.; Venkataramanan, R.; et al. Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: A comparison with adult human hepatocytes. Drug Metab. Dispos. 2013, 41, 296-304.
84. Hardikar, W.; Ananthanarayanan, M.; Suchy, F.J. Differential ontogenic regulation of basolateral and canalicular bile acid transport proteins in rat liver. J. Biol. Chem. 1995, 270, 20841-20846.
85. St-Pierre, M.V.; Stallmach, T.; Freimoser Grundschober, A.; Dufour, J.F.; Serrano, M.A.; Marin, J.J.; Sugiyama, Y.; Meier, P.J. Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287, R1505-R1516.
86. Alnouti, Y.; Petrick, J.S.; Klaassen, C.D. Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab. Dispos. 2006, 34, 477-482.
87. Cheng, X.; Maher, J.; Chen, C.; Klaassen, C.D. Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps). Drug Metab. Dispos. 2005, 33, 1062-1073.
88. Van Kalken, C.K.; Giaccone, G.; van der Valk, P.; Kuiper, C.M.; Hadisaputro, M.M.; Bosma, S.A.; Scheper, R.J.; Meijer, C.J.; Pinedo, H.M. Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am. J. Pathol 1992, 141, 1063-1072.
89. Rosati, A.; Maniori, S.; Decorti, G.; Candussio, L.; Giraldi, T.; Bartoli, F. Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. Dev. Growth Differ. 2003, 45, 377-387.
90. Cui, Y.J.; Cheng, X.; Weaver, Y.M.; Klaassen, C.D. Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice. Drug Metab. Dispos. 2009, 37, 203-210.
91. Zinchuk, V.S.; Okada, T.; Akimaru, K.; Seguchi, H. Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver. Am. J. Physiol. Gastrointest Liver Physiol. 2002, 282, G540-G548.
92. Maher, J.M.; Slitt, A.L.; Cherrington, N.J.; Cheng, X.; Klaassen, C.D. Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metab. Dispos. 2005, 33, 947-955.
93. Dubuisson, C.; Cresteil, D.; Desrochers, M.; Decimo, D.; Hadchouel, M.; Jacquemin, E. Ontogenic expression of the Na(+)-independent organic anion transporting polypeptide (oatp) in rat liver and kidney. J. Hepatol. 1996, 25, 932-940.
94. Lee, J.S.; Ward, W.O.; Liu, J.; Ren, H.; Vallanat, B.; Delker, D.; Corton, J.C. Hepatic xenobiotic metabolizing enzyme and transporter gene expression through the life stages of the mouse. PLoS One 2011, 6, e24381.
95. Fakhoury, M.; de Beaumais, T.; Guimiot, F.; Azougagh, S.; Elie, V.; Medard, Y.; Delezoide, A.L.; Jacqz-Aigrain, E. mRNA expression of MDR1 and major metabolising enzymes in human fetal tissues. Drug Metab. Pharmacokinet 2009, 24, 529-536.
96. Klaassen, C.D.; Aleksunes, L.M. Xenobiotic, bile acid, and cholesterol transporters: Function and regulation. Pharmacol. Rev. 2010, 62, 1-96.
97. Tomer, G.; Ananthanarayanan, M.; Weymann, A.; Balasubramanian, N.; Suchy, F.J. Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2. Pediatr. Res. 2003, 53, 288-294.
98. Zhou, S.; Zong, Y.; Ney, P.A.; Nair, G.; Stewart, C.F.; Sorrentino, B.P. Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels. Blood 2005, 105, 2571-2576.
99. Boyer, J.L.; Hagenbuch, B.; Ananthanarayanan, M.; Suchy, F.; Stieger, B.; Meier, P.J. Phylogenic and ontogenic expression of hepatocellular bile acid transport. Proc. Natl. Acad. Sci. USA 1993, 90, 435-438.
100. Suchy, F.J.; Bucuvalas, J.C.; Goodrich, A.L.; Moyer, M.S.; Blitzer, B.L. Taurocholate transport and Na+-K+-ATPase activity in fetal and neonatal rat liver plasma membrane vesicles. Am. J. Physiol. 1986, 251, G665-G673.
101. Landry, C.; Clotman, F.; Hioki, T.; Oda, H.; Picard, J.J.; Lemaigre, F.P.; Rousseau, G.G. HNF-6 is expressed in endoderm derivatives and nervous system of the mouse embryo and participates to the cross-regulatory network of liver-enriched transcription factors. Dev. Biol. 1997, 192, 247-257.